TY - JOUR
T1 - Cell Metabolic Alterations due to Mcph1 Mutation in Microcephaly
AU - Journiac, Nathalie
AU - Gilabert-Juan, Javier
AU - Cipriani, Sara
AU - Benit, Paule
AU - Liu, Xiaoqian
AU - Jacquier, Sandrine
AU - Faivre, Valérie
AU - Delahaye-Duriez, Andrée
AU - Csaba, Zsolt
AU - Hourcade, Tristan
AU - Melinte, Eliza
AU - Lebon, Sophie
AU - Violle-Poirsier, Céline
AU - Oury, Jean-François
AU - Adle-Biassette, Homa
AU - Wang, Zhao-Qi
AU - Mani, Shyamala
AU - Rustin, Pierre
AU - Gressens, Pierre
AU - Nardelli, Jeannette
N1 - Copyright © 2020 Institut National de la Sante et de la Recherche Médicale. Published by Elsevier Inc. All rights reserved.
PY - 2020/4/14
Y1 - 2020/4/14
N2 - A distinctive feature of neocortical development is the highly coordinated production of different progenitor cell subtypes, which are critical for ensuring adequate neurogenic outcome and the development of normal neocortical size. To further understand the mechanisms that underlie neocortical growth, we focused our studies on the microcephaly gene Mcph1, and we report here that Mcph1 (1) exerts its functions in rapidly dividing apical radial glial cells (aRGCs) during mouse neocortical development stages that precede indirect neurogenesis; (2) is expressed at mitochondria; and (3) controls the proper proliferation and survival of RGCs, potentially through crosstalk with cellular metabolic pathways involving the stimulation of mitochondrial activity via VDAC1/GRP75 and AKT/HK2/VDAC1 and glutaminolysis via ATF4/PCK2. We currently report the description of a MCPH-gene implication in the interplay between bioenergetic pathways and neocortical growth, thus pointing to alterations of cellular metabolic pathways, in particular glutaminolysis, as a possible cause of microcephalic pathogenesis.
AB - A distinctive feature of neocortical development is the highly coordinated production of different progenitor cell subtypes, which are critical for ensuring adequate neurogenic outcome and the development of normal neocortical size. To further understand the mechanisms that underlie neocortical growth, we focused our studies on the microcephaly gene Mcph1, and we report here that Mcph1 (1) exerts its functions in rapidly dividing apical radial glial cells (aRGCs) during mouse neocortical development stages that precede indirect neurogenesis; (2) is expressed at mitochondria; and (3) controls the proper proliferation and survival of RGCs, potentially through crosstalk with cellular metabolic pathways involving the stimulation of mitochondrial activity via VDAC1/GRP75 and AKT/HK2/VDAC1 and glutaminolysis via ATF4/PCK2. We currently report the description of a MCPH-gene implication in the interplay between bioenergetic pathways and neocortical growth, thus pointing to alterations of cellular metabolic pathways, in particular glutaminolysis, as a possible cause of microcephalic pathogenesis.
KW - ATF4
KW - GRP75
KW - PCK2
KW - VDAC1
UR - http://www.scopus.com/inward/record.url?scp=85083018095&partnerID=8YFLogxK
U2 - 10.1016/j.celrep.2020.03.070
DO - 10.1016/j.celrep.2020.03.070
M3 - Article
C2 - 32294449
SN - 2211-1247
VL - 31
JO - Cell Reports
JF - Cell Reports
IS - 2
M1 - 107506
ER -